A Randomized Double-blind, Placebo-and Active Comparator-Controlled 2-Part Study to Evaluate the Efficacy of MK2295 in Patients With Postoperative Dental Pain
Latest Information Update: 06 May 2022
Price :
$35 *
At a glance
- Drugs MK 2295 (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 06 Nov 2006 New trial record.